Fieldpoint Private Securities, LLC Zentalis Pharmaceuticals, Inc. Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 902 shares of ZNTL stock, worth $2,868. This represents 0.01% of its overall portfolio holdings.
Number of Shares
902
Previous 904
0.22%
Holding current value
$2,868
Previous $42,000
40.48%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ZNTL
# of Institutions
142Shares Held
67.9MCall Options Held
48.5KPut Options Held
89.6K-
Matrix Capital Management Company, LP Waltham, MA14MShares$44.4 Million2.45% of portfolio
-
Eventide Asset Management, LLC Boston, MA8.55MShares$27.2 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$15.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.61MShares$14.7 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA3.11MShares$9.88 Million2.71% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $181M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...